Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy

Neuroradiology

Volumn 46, Issue 4, 2004, Pages 277-281

  Kizu, O ^a   Yamada, K ^a   Ito, H ^a   Nishimura, T ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Frontotemporal lobar degeneration; Magnetic resonance spectroscopy; N acetylaspartate; Posterior cingulate gyrus; Senile dementia of Alzheimer type

Indexed keywords

CHOLINE; CREATININE; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN DEGENERATION; BRAIN LEVEL; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTAL LOBE; HEMISPHERE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TEMPORAL LOBE;

ADULT; AGED; ALZHEIMER DISEASE; ASPARTIC ACID; CASE-CONTROL STUDIES; CHOLINE; CREATINE; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROGNOSIS;

EID: 2342628518     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-004-1167-5     Document Type: Article

References (27)

1. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D (1999) Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66: 184-188
2. Mirra SS, Heyman A, McKeel D, et al (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
3. Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Arch Psychiatr Nervenkr 223: 15-33
4. Neary D, Snowden D, Gustafson JS, et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554
5. Valenzuela MJ, Sachdev P (2001) Magnetic resonance spectroscopy in AD. Neurology 56: 592-598
6. Ernst T, Chang L, Melchor R, Mehringer CM (1997) Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203: 829-836
7. Holshouser BA, Komu M, Moller HE, et al (1995) Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn Reson Med 33: 589-594
8. Hoang TQ, Bluml S, Dubowitz DJ, et al (1998) Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 50: 1033-1040
9. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944
11. Kizu O, Yamada K, Nishimura T (2001) Proton chemical shift imaging in normal pressure hydrocephalus. AJNR 22: 1659-1664
12. Patel TB, Clark JB (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184: 539-546
13. Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13: 981-989
14. Moats RA, Ernst T, Shonk TK, Ross BD (1994) Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32: 110-115
15. Hsu YY, Du AT, Schuff N, Weiner MW (2001) Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol 14: 145-166
16. Kantarci K, Jack CR Jr, Xu YC, et al (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 55: 210-217
17. Parnetti L, Lowenthal DT, Presciutti O, et al (1996) 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 44: 133-138
18. Parnetti L, Tarducci R, Presciutti O, et al (1997) Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Mech Ageing Dev 97: 9-14
19. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD (1993) Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 187: 433-437
20. Tedeschi G, Bertolino A, Lundbom N, et al (1996) Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 47: 696-704
21. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42: 85-94
22. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1: 103-116
23. Hugg JW, Kuzniecky RI, Gilliam FG, Morawetz RB, Fraught RE, Hetherington HP (1996) Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 40: 236-239
24. Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4: 47-52
25. Heiss WD, Kessler J, Szelies B, Grond M, Fink G, Herholz K (1991) Positron emission tomography in the differential diagnosis of organic dementias. J Neural Transm [Suppl 33]: 13-19
26. Ishii K, Sakamoto S, Sasaki M, et al (1998) Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 39: 1875-1878
27. Kaufer DI, Miller BL, Itti L, et al (1997) Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology 48: 978-985